The reported statements, read against the company's own industry.
As of FY2024 (year ended December 31, 2024). Newer annual figures aren't yet on file.
Financials view
Market Capitalization
18.02BCNY
2.69B · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
101.00x
vs Conglomerates peers
Updated Sep 21, 2026
Revenue (TTM)
2.44BCNY
364.61M · vs all stocks (USD)
Updated Sep 21, 2026
Profit Margin
6.78%
vs Conglomerates peers
Updated Sep 21, 2026
Beta
0.8390x
vs all stocks
Updated Sep 21, 2026
52-Week Change
40.60%
vs all stocks
Updated Sep 21, 2026
Market Capitalization
18.02BCNY
2.69B · vs all stocks (USD)
Updated Sep 21, 2026
Enterprise Value
18.92BCNY
2.83B · vs all stocks (USD)
Updated Sep 21, 2026
Trailing P/E
101.00x
vs Conglomerates peers
Updated Sep 21, 2026
Price to Sales (TTM)
7.38x
vs Conglomerates peers
Updated Sep 21, 2026
Price to Book (MRQ)
4.83x
vs Conglomerates peers
Updated Sep 21, 2026
Enterprise to Revenue
7.75x
vs Conglomerates peers
Updated Sep 21, 2026
Gross Margin
10.20%
vs Conglomerates peers
Updated Sep 21, 2026
Profit Margin
6.78%
vs Conglomerates peers
Updated Sep 21, 2026
Operating Margin
2.85%
vs Conglomerates peers
Updated Sep 21, 2026
Return on Assets (TTM)
-0.60%
vs Conglomerates peers
Updated Sep 21, 2026
Return on Equity (TTM)
4.55%
vs Conglomerates peers
Updated Sep 21, 2026
Revenue (TTM)
2.44BCNY
364.61M · vs all stocks (USD)
Updated Sep 21, 2026
Revenue per Share (TTM)
0.8690CNYUpdated Sep 21, 2026
Quarterly Revenue Growth
63.70%
vs Conglomerates peers
Updated Sep 21, 2026
Gross Profit (TTM)
207.45MCNY
30.98M · vs all stocks (USD)
Updated Sep 21, 2026
EBITDA (TTM)
299.13MCNY
44.67M · vs all stocks (USD)
Updated Sep 21, 2026
Net Income (TTM)
165.59MCNY
24.73M · vs all stocks (USD)
Updated Sep 21, 2026
Quarterly Earnings Growth (YoY)
-65.20%
vs Conglomerates peers
Updated Sep 21, 2026
Operating Cash Flow (TTM)
-309.29MCNY
-46.19M · vs all stocks (USD)
Updated Sep 21, 2026
Levered Free Cash Flow (TTM)
-99.60MCNY
-14.87M · vs all stocks (USD)
Updated Sep 21, 2026
5-Year Average Dividend Yield
1.49%
vs all stocks
Updated Sep 21, 2026
Payout Ratio
0.00%
vs Conglomerates peers
Updated Sep 21, 2026
Revenue
1.33BCNYFY2024 · Dec 31, 2024
Cost of Goods Sold
1.17BCNYFY2024 · Dec 31, 2024
Gross Profit
159.78MCNYFY2024 · Dec 31, 2024
Operating Income
40.60MCNY
6.06M · vs all stocks (USD)
FY2024 · Dec 31, 2024
Pre-tax Income
207.74MCNYFY2024 · Dec 31, 2024
Income Tax Expense
42.18MCNYFY2024 · Dec 31, 2024
Net Income
165.55MCNYFY2024 · Dec 31, 2024
EBIT
230.72MCNYFY2024 · Dec 31, 2024
EBITDA (Income Statement)
382.75MCNYFY2024 · Dec 31, 2024
Research & Development
40.76MCNYFY2024 · Dec 31, 2024
Selling, General & Administrative
37.05MCNYFY2024 · Dec 31, 2024
Other Operating Expenses
11.53MCNYFY2024 · Dec 31, 2024
Non-operating Interest Income
8.27MCNYFY2024 · Dec 31, 2024
Non-operating Interest Expense
22.99MCNYFY2024 · Dec 31, 2024
EPS (Basic)
0.0600CNYFY2024 · Dec 31, 2024
EPS (Diluted)
0.0600CNYFY2024 · Dec 31, 2024
Basic Shares Outstanding
3.16BSharesFY2024 · Dec 31, 2024
Diluted Shares Outstanding
3.16BSharesFY2024 · Dec 31, 2024
Net Income from Continuing Operations
165.55MCNYFY2024 · Dec 31, 2024
Minority Interests (P&L)
23.90MCNYFY2024 · Dec 31, 2024
Preferred Stock Dividends
0.00CNYFY2024 · Dec 31, 2024
Operating Cash Flow
-95.52MCNYFY2024 · Dec 31, 2024
Free Cash Flow
-195.75MCNYFY2024 · Dec 31, 2024
Cash & Cash Equivalents (End of Period)
633.20MCNYFY2024 · Dec 31, 2024
Starting Profit (CF Statement)
165.55MCNYFY2024 · Dec 31, 2024
Other Non-cash Items
18.66MCNYFY2024 · Dec 31, 2024
Change in Accounts Receivable (CF)
-203.41MCNYFY2024 · Dec 31, 2024
Change in Other Assets/Liabilities
-76.33MCNYFY2024 · Dec 31, 2024
Capital Expenditures
-100.23MCNYFY2024 · Dec 31, 2024
Net Acquisitions
8.20MCNYFY2024 · Dec 31, 2024
Purchase of Investments
-466.23MCNYFY2024 · Dec 31, 2024
Sale of Investments
456.81MCNYFY2024 · Dec 31, 2024
Other Investing Activity
7.71MCNYFY2024 · Dec 31, 2024
Net Investing Cash Flow
-93.74MCNYFY2024 · Dec 31, 2024
Long-term Debt Issuance
159.70MCNYFY2024 · Dec 31, 2024
Long-term Debt Payments
-61.78MCNYFY2024 · Dec 31, 2024
Common Dividends Paid
-13.28MCNYFY2024 · Dec 31, 2024
Other Financing Charges
-46.49MCNYFY2024 · Dec 31, 2024
Net Financing Cash Flow
38.15MCNYFY2024 · Dec 31, 2024
Shares Outstanding
2.97BSharesUpdated Sep 21, 2026
Float Shares
1.65BSharesUpdated Sep 21, 2026
% Held by Insiders
44.50%
vs all stocks
Updated Sep 21, 2026
% Held by Institutions
1.69%
vs all stocks
Updated Sep 21, 2026
Total Cash (MRQ)
661.22MCNY
98.74M · vs all stocks (USD)
Updated Sep 21, 2026
Total Cash per Share (MRQ)
0.2220CNYUpdated Sep 21, 2026
Total Debt (MRQ)
1.55BCNY
232.13M · vs all stocks (USD)
Updated Sep 21, 2026
Total Debt to Equity (MRQ)
0.4168x
vs Conglomerates peers
Updated Sep 21, 2026
Current Ratio (MRQ)
1.16x
vs Conglomerates peers
Updated Sep 21, 2026
Book Value per Share (MRQ)
1.25CNYUpdated Sep 21, 2026
Total Assets
4.50BCNY
671.36M · vs all stocks (USD)
FY2024 · Dec 31, 2024
Total Current Assets
1.50BCNYFY2024 · Dec 31, 2024
Total Liabilities
1.08BCNYFY2024 · Dec 31, 2024
Total Non-current Assets
2.99BCNYFY2024 · Dec 31, 2024
Total Non-current Liabilities
479.37MCNYFY2024 · Dec 31, 2024
Total Current Liabilities
601.16MCNYFY2024 · Dec 31, 2024
Cash
430.72MCNYFY2024 · Dec 31, 2024
Cash Equivalents
193.78MCNYFY2024 · Dec 31, 2024
Cash & Cash Equivalents
635.26MCNYFY2024 · Dec 31, 2024
Other Short-term Investments
211.65MCNYFY2024 · Dec 31, 2024
Accounts Receivable
198.94MCNYFY2024 · Dec 31, 2024
Inventory
262.74MCNYFY2024 · Dec 31, 2024
Accounts Payable
298.77MCNYFY2024 · Dec 31, 2024
Short-term Debt
141.71MCNYFY2024 · Dec 31, 2024
Other Current Liabilities
1.23MCNYFY2024 · Dec 31, 2024
Long-term Debt
387.33MCNYFY2024 · Dec 31, 2024
Other Non-current Liabilities
574.34KCNYFY2024 · Dec 31, 2024
Common Stock (Book)
3.06BCNYFY2024 · Dec 31, 2024
Retained Earnings
194.82MCNYFY2024 · Dec 31, 2024
Total Shareholders' Equity
3.42BCNY
510.00M · vs all stocks (USD)
FY2024 · Dec 31, 2024
Treasury Stock
200.04MCNYFY2024 · Dec 31, 2024
52-Week Low
3.96CNYUpdated Sep 21, 2026
52-Week High
11.99CNYUpdated Sep 21, 2026
52-Week Change
40.60%
vs all stocks
Updated Sep 21, 2026
Beta
0.8390x
vs all stocks
Updated Sep 21, 2026
50-Day MA
5.98CNYUpdated Sep 21, 2026
200-Day MA
6.08CNYUpdated Sep 21, 2026
Avg 10-Day Volume
82.48MSharesUpdated Sep 21, 2026
Avg 30-Day Volume
105.09MSharesUpdated Sep 21, 2026
Diluted EPS (TTM)
0.0600CNYUpdated Sep 21, 2026
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Upstream position: supplies 8 industries, depends on 0Notable
Outgoing: 8.00Incoming: 0.00
Scale
Market cap is $2.69B, above the global median of $1.18BNotable
Market cap (USD): 2,691,635,949.905Global Median: 1,180,223,658.953
Companies that share the same coordination system — how they create, deliver, or capture value.